Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 412

Showing 1-25 of 412 citing articles:

New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 409
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro‐Bosso, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2478-2478
Open Access | Times Cited: 234
Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 229
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Hui Li, Yujun Kim, Hyoje Jung, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 21, pp. 8957-9008
Closed Access | Times Cited: 214
The cannabis withdrawal syndrome: current insights
Udo Bonnet, Ulrich W. Preuss
Substance Abuse and Rehabilitation (2017) Vol. Volume 8, pp. 9-37
Open Access | Times Cited: 197
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Kazuhito Tsuboi, Toru Uyama, Yasuo Okamoto, et al.
Inflammation and Regeneration (2018) Vol. 38, Iss. 1
Open Access | Times Cited: 187
Review of the neurological benefits of phytocannabinoids
Joseph C. Maroon, J Bost
Surgical Neurology International (2018) Vol. 9, Iss. 1, pp. 91-91
Open Access | Times Cited: 183
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito, Marta Seijo-Vila, Miriam Caro-Villalobos, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 285-293
Closed Access | Times Cited: 163
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos, Manoela V. Fogaça, Franciele Franco Scarante, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 154
Beyond THC and Endocannabinoids
Pál Pacher, Natalya M. Kogan, Raphael Mechoulam
The Annual Review of Pharmacology and Toxicology (2019) Vol. 60, Iss. 1, pp. 637-659
Closed Access | Times Cited: 143
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Maurício dos Santos Pereira, Franscisco S. Guimarães, Elaine Aparecida Del Bel, et al.
Glia (2019) Vol. 68, Iss. 3, pp. 561-573
Closed Access | Times Cited: 131
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Let thy food be thy medicine….when possible
Renger F. Witkamp, Klaske van Norren
European Journal of Pharmacology (2018) Vol. 836, pp. 102-114
Open Access | Times Cited: 112
Fever and hypothermia in systemic inflammation
András Garami, Alexandre A. Steiner, Andrej A. Romanovsky
Handbook of clinical neurology (2018), pp. 565-597
Closed Access | Times Cited: 112
The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman, Marek Toczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6740-6740
Open Access | Times Cited: 104
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martı́n-Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 103
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
Amanda J. Sales, Carlos C. Crestani, Francisco Silveira Guimarães, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 86, pp. 255-261
Open Access | Times Cited: 102
Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
Anna Jastrząb, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Cells (2019) Vol. 8, Iss. 8, pp. 827-827
Open Access | Times Cited: 102
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar‐Sela, Idan Cohen, Salvatore Campisi‐Pinto, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2447-2447
Open Access | Times Cited: 101
Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation
János Pálóczi, Zoltán V. Varga, George Hasko, et al.
Antioxidants and Redox Signaling (2017) Vol. 29, Iss. 1, pp. 75-108
Open Access | Times Cited: 96
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas, María Scherma, Walter Fratta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1863-1863
Open Access | Times Cited: 96
Page 1 - Next Page

Scroll to top